clofibrate has been researched along with isoproterenol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bleve, L; Colabufo, NA; Jockers, R; Milazzo, FM; Perrone, MG; Santandrea, E; Sciarroni, AF; Scilimati, A; Vitale, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Greenberg, BP; Wexler, BC | 1 |
| Ditschuneit, H; Ditschuneit, HH; Fussgänger, R | 1 |
| Miller, NE; Mjos, OD; Oliver, MF | 1 |
| Carlson, LA | 1 |
| Miller, NE; Mjos, OD; Oliver, MF; Riemersma, RA | 1 |
| Fairhurst, AS; Peabody, T; Wickie, G | 1 |
| Mjøs, OD; Vik-Mo, H | 1 |
| Gupta, B; Prasad, DN; Saxena, KK; Singh, RC; Srivastava, RK | 1 |
| Forest, C; Franckhauser-Vogel, S; Glorian, M | 1 |
| Forest, C; Franckhauser-Vogel, S; Glorian, M; Robin, D; Robin, P | 1 |
1 review(s) available for clofibrate and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for clofibrate and isoproterenol
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
Topics: Adenylyl Cyclases; Adrenergic beta-3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Inverse Agonism; Humans; Molecular Structure; Receptors, Adrenergic, beta-3; Stereoisomerism; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Blood Urea Nitrogen; Clofibrate; Coronary Disease; Coronary Vessels; Corticosterone; Creatine Kinase; Female; Isoproterenol; L-Lactate Dehydrogenase; Lipids; Male; Myocardial Infarction; Myocardium; Necrosis; Rats | 1978 |
[Comparative studies on the effect of commercial lipid-lowering substances on the lipolysis of isolated rat and human fat cells].
Topics: Adipose Tissue; Animals; Clofibrate; Humans; Insulin; Isoproterenol; Nicotinic Acids; Rats; Theophylline | 1978 |
Effects of p-chlorophenoxyisobutyrate on free fatty acid mobilization from canine subcutaneous adipose tissue in situ.
Topics: Adipose Tissue; Animals; Clofibrate; Dogs; Fatty Acids, Nonesterified; Female; Glycerol; Isoproterenol; Lipid Mobilization; Regional Blood Flow | 1976 |
Effect of gemfibrozil in vitro on fat-mobilizing lipolysis in human adipose tissue.
Topics: Adipose Tissue; Clofibrate; Depression, Chemical; Humans; Hypolipidemic Agents; In Vitro Techniques; Isoproterenol; Lipid Metabolism; Lipid Mobilization; Norepinephrine; Theophylline; Valerates; Xylenes | 1976 |
Effects of p-chlorophenoxyisobutyrate on myocardial free fatty acid extraction, ventricular blood flow, and epicardial ST-segment elevation during coronary occlusion in dogs.
Topics: Animals; Blood Pressure; Clofibrate; Coronary Circulation; Coronary Disease; Dogs; Electrophysiology; Fatty Acids, Nonesterified; Female; Heart; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardium | 1976 |
Clofibrate, calcium and cardiac muscle.
Topics: Animals; Calcium; Clofibrate; Heart; Heart Rate; In Vitro Techniques; Ion Channels; Isoproterenol; Male; Mitochondria, Heart; Myocardial Contraction; Rabbits; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1982 |
Acute effects of p-chlorophenoxyisobutyrate on myocardial metabolism and performance in dogs.
Topics: Animals; Clofibrate; Dogs; Fatty Acids, Nonesterified; Female; Heart; Hemodynamics; Isoproterenol; Lipid Metabolism; Male; Myocardium; Oxygen Consumption | 1981 |
Clofibrate, fibrinolysis and experimental myocardial damage.
Topics: Animals; Cardiomyopathies; Clofibrate; Fibrinolysis; Isoproterenol; Male; Rats | 1981 |
Glucocorticoids use a positive liver element to repress fibrate-induced adipose transcription of the phosphoenolpyruvate carboxykinase gene.
Topics: 3T3 Cells; Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Extracts; Clofibrate; Dexamethasone; DNA-Binding Proteins; Gene Expression Regulation, Enzymologic; Glucocorticoids; Hypolipidemic Agents; Isoproterenol; Liver; Mice; Mifepristone; Mutation; Phosphoenolpyruvate Carboxykinase (GTP); Promoter Regions, Genetic; Recombinant Fusion Proteins; Repetitive Sequences, Nucleic Acid; Transcriptional Activation | 1997 |
Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes.
Topics: 3T3 Cells; Adipocytes; Adrenergic beta-Agonists; Animals; Clofibrate; Dexamethasone; Enzyme Induction; Fatty Acids; Gene Expression Regulation, Enzymologic; Genes; Glucocorticoids; Hypoglycemic Agents; Isoproterenol; Male; Mice; Phosphoenolpyruvate Carboxykinase (GTP); Protein Biosynthesis; Proteins; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Regulatory Sequences, Nucleic Acid; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors | 1998 |